In the latest trading session, Oscar Health, Inc. (OSCR) closed at $14.45, marking a +1.76% move from the previous day. This change outpaced the S&P 500's 0.4% gain on the day. Meanwhile, the Dow ...

Fintel reports that on July 25, 2025, Baird downgraded their outlook for Oscar Health (NYSE:OSCR) from Outperform to Neutral.

Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Oscar Health earlier this year filed for an initial public offering. On Friday Aug. 13, the health ... More insurer said it would expand to three new states to sell coverage for 2022.

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...

Oscar Health CEO Mario Schlosser speaks at the 2017 Best in the Business Awards at Trianon Ballroom ... More at The New York Hilton Midtown on November 9, 2017 in New York City.

Oscar Health was co-founded in 2012 by Josh Kushner, the brother of the son-in-law of former President Donald Trump. During his tenure, Trump made a number of moves to end protections for LGBTQ+ ...

Oscar Health recorded a $610 million net loss in 2022, up from $571 million the prior year, but the company predicts a better 2023.